New Migraine Treatment Option Approved for NHS Scotland Patients
AbbVie has received approval for a new migraine treatment called AQUIPTA (atogepant) to be used by adults in NHS Scotland, […]
Pharmaceutical News
New Hope for Advanced Parkinson’s: Promising Results from an Experimental Oral Drug
A Danish pharmaceutical company called Lundbeck has shared early findings from a small clinical trial of a new oral medication
Pharmaceutical News
Roche Partners with Rona Therapeutics to Develop New Obesity Treatment with $1.06 Billion Deal
Roche, a leading pharmaceutical company, has agreed to pay up to $1.06 billion to Rona Therapeutics for the rights to
New $58 Million Funding to Develop Potential Once-Daily Pill for Rare Bleeding Disorder HHT
RougeTx, a biotechnology company, has raised $58 million in its first major funding round to develop a new oral treatment
New Advances in Pancreatic Cancer and Rare Disease Treatments Highlighted This Week in Pharma
This week brought important updates in the world of pharmaceuticals and healthcare. Here’s what you need to know, explained in
Pharmaceutical News
Bayer Invests $2.2 Billion to Build New Pharmaceutical Factory in Ohio, Creating 600 Jobs
Bayer, a global pharmaceutical company, is spending $2.2 billion to build a new, highly automated manufacturing site in New Albany,
Pharmaceutical News
2026 Nobel Prize in Medicine Awarded for Revolutionary Brain Research Tool Called Optogenetics
A major breakthrough in brain research has earned three scientists the 2026 Nobel Prize in Physiology or Medicine. Their work
Parents Urge Pregnant Women to Join New Vaccine Study to Protect Babies from Serious Infections
Mothers whose babies became very ill with sepsis or meningitis caused by a bacteria called group B streptococcus (GBS) are
New NHS-approved drug offers hope for adults with rare genetic blood fat disorder
A new treatment called Tryngolza (olezarsen) has been recommended by NICE (National Institute for Health and Care Excellence) for adults
Pharmaceutical News
Major Drug Companies Expand Partnership to Bring More Affordable Biologic Medicines to Patients
A partnership between Samsung Bioepis and Teva Pharmaceuticals has grown to include up to six new potential biosimilar medicines. This